General Information of the Compound
Compound ID
CP0054573
Compound Name
CHEBI:63453
    Show/Hide
Synonyms
1035270-39-3
2167OG1EKJ
AZD 4547
AZD-4547
AZD4547
CHEBI:63453
KB-74810
N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-rel-3,5-dimethylpiperazin-1-yl)benzamide
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide
N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-(cis-3,5-dimethylpiperazin-1-yl)benzamide
UNII-2167OG1EKJ
rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide
    Show/Hide
Structure
Formula
C26H33N5O3
Molecular Weight
463.582
Canonical SMILES
COc1cc(CCc2cc(NC(=O)c3ccc(cc3)N3C[C@H](C)N[C@H](C)C3)n[nH]2)cc(OC)c1
    Show/Hide
InChI
InChI=1S/C26H33N5O3/c1-17-15-31(16-18(2)27-17)22-9-6-20(7-10-22)26(32)28-25-13-21(29-30-25)8-5-19-11-23(33-3)14-24(12-19)34-4/h6-7,9-14,17-18,27H,5,8,15-16H2,1-4H3,(H2,28,29,30,32)/t17-,18+
    Show/Hide
InChIKey
VRQMAABPASPXMW-HDICACEKSA-N
Physicochemical Property
logP
3.651
Rotatable Bonds
8
Heavy Atom Count
34
Polar Areas
91.51
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
6
Complexity
34

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 51039095
SID: 136350053
ChEMBL ID
CHEMBL3348846
DrugBank ID
DB12247,DB18442
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000434 KG-1 Homo sapiens (Human)  2
1
IC50 < 0.2 nM
   TI
   LI
   LO
   TS
2
IC50 = 16.1 nM
   TI
   LI
   LO
   TS
CL000958 NCI-H1581 Homo sapiens (Human)  2
1
IC50 = 32.9 nM
   TI
   LI
   LO
   TS
2
IC50 = 62.6 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.2 nM
2 IC50 = 0.6 nM
3 IC50 = 0.7 nM
4 IC50 = 0.8 nM
5 IC50 = 0.9 nM
6 IC50 = 1.1 nM
7 IC50 = 1.2 nM
8 IC50 = 1.3 nM
9 IC50 = 1.5 nM
Protein ID: PT01115, Fibroblast growth factor receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000431 SNU-16 Homo sapiens (Human)  2
1
IC50 = 3.6 nM
   TI
   LI
   LO
   TS
2
IC50 = 25.4 nM
   TI
   LI
   LO
   TS
CL000432 KATO III Homo sapiens (Human)  2
1
IC50 = 14.1 nM
   TI
   LI
   LO
   TS
2
IC50 = 20.2 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.4 nM
2 IC50 = 0.6 nM
3 IC50 = 1.1 nM
4 IC50 = 1.2 nM
5 IC50 = 2.5 nM
6 IC50 = 3.2 nM
Protein ID: PT01411, Fibroblast growth factor receptor 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000433 RT-112 Homo sapiens (Human)  2
1
IC50 = 0.6 nM
   TI
   LI
   LO
   TS
2
IC50 = 27 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 1.8 nM
2 IC50 = 3.4 nM
3 IC50 = 5.2 nM
4 IC50 = 5.5 nM
5 IC50 = 5.6 nM
6 IC50 = 27 nM
Protein ID: PT01343, Fibroblast growth factor receptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  4
1
IC50 = 56 nM
   TI
   LI
   LO
   TS
2
IC50 = 67 nM
   TI
   LI
   LO
   TS
3
IC50 = 103 nM
   TI
   LI
   LO
   TS
4
IC50 = 655 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 45.7 nM
2 IC50 = 49.8 nM
3 IC50 = 56 nM
4 IC50 = 165 nM
5 IC50 = 2510 nM
Protein ID: PT07029, Fibroblast growth factor receptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000077 Ba/F3 Mus musculus (Mouse)  2
1
IC50 = 348 nM
   TI
   LI
   LO
   TS
2
IC50 = 519 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( AZD4547 )
Drug Name AZD4547
Company AstraZeneca
Indication
Solid tumour/cancer
Phase 2/3
Solid tumour/cancer
Phase 2
Target(s)
Fibroblast growth factor receptor 1 (FGFR1)
Modulator